Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Helena

Helena Alfonzo, Chestnut Hill, MA US

Patent application numberDescriptionPublished
20110142804NANOFIBER SCAFFOLD - The invention is directed to a device and method to prevent migration of Human Mesenchymal Stem Cells (hMSCs) from a delivery site while allowing communication between the stem cells and native cardiomyocytes. The device is characterized by scaffold pore size, fiber diameter and biomaterial selection. The invention includes a two part polyurethane scaffold that prevents migration of stem cells, allows gap junction formation through pores and is packaged for minimally invasive delivery.06-16-2011

Helena Andersson, Alingsas SE

Patent application numberDescriptionPublished
20090123324Iron-Base Alloy Containing Chromium-Tungsten Carbide And a Method Of Producing It - A method and cast wear resistant component made of an alloy that includes carbon, tungsten, chromium, and cobalt with the balance essentially iron and other alloying components made using waste, surplus or worn-out cemented carbide product, such as cemented carbide cutting tool inserts. In one method, the alloy further includes silicon, manganese, nickel, titanium, and molybdenum. In practicing the method, pieces of waste, surplus or worn-out cemented carbide product having tungsten carbide (WC) are added to a cast iron alloy melt. The melt includes enough chromium to control solubility of the WC. In one method, precipitated carbide structure having chromium and carbon is produced with tungsten in the melt being substitutionally dissolved. In one implementation, tungsten is substitutionally dissolved in a lattice of the precipitated carbide structure. Carbide can be added to the melt via super inoculation. The cast wear resistant component can be a cutting tool.05-14-2009

Helena Bilerova, Liberec CZ

Patent application numberDescriptionPublished
20100260809Preparation For Wound Healing And Prevention Of Bandage Adhesion To The Wound, Containing Chitosan-Glucan - The invention relates to a preparation containing a pharmacologically suitable chitosan-glucan complex or a salt thereof, either alone or in combination with one or more polysaccharides or suitable salts thereof and an antiseptic agent, that is intended for wound healing and that, besides accelerating wound healing, is at the same time able to prevent a bandage adhesion to the wound. The preparation according to the invention, having been applied, indirectly supports the healing processes in the wound and drains the redundant secretion together with the tissue mediators and enzymes that support the healing. By doing this, it provides for the necessary hydration of the wound and its surroundings, without any maceration of the surrounding skin or drying and sticking to the wound. An addition of antiseptic agents prevents a further infection. The preparation contains 0.01 to 100% by weight of chitosan-glucan complex, 0 to 99.99% by weight of another polysaccharide and 0 to 50% by weight of an antiseptic agent.10-14-2010

Helena Camps Ramírez De Cartagena, Rubi ES

Patent application numberDescriptionPublished
20100204476Process for preparing a leukotriene antagonist and an intermediate thereof - Dicyclohexylamine salt of formula (IIa) or a pharmaceutically acceptable solvate thereof, including a hydrate, and its process for preparation are provided. The invention also relates to processes for the preparation of montelukast of formula (I) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, including a hydrate, based on the conversion of a salt of formula (IIa) into its form of free acid, followed by reaction with a compound of formula (III) CH3MgX, wherein X is halogen, in a suitable solvent, optionally in the presence of a Lewis acid.08-12-2010

Helena Camps Ramírez De Cartagena, Rubi ES

Patent application numberDescriptionPublished
20100204476Process for preparing a leukotriene antagonist and an intermediate thereof - Dicyclohexylamine salt of formula (IIa) or a pharmaceutically acceptable solvate thereof, including a hydrate, and its process for preparation are provided. The invention also relates to processes for the preparation of montelukast of formula (I) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, including a hydrate, based on the conversion of a salt of formula (IIa) into its form of free acid, followed by reaction with a compound of formula (III) CH3MgX, wherein X is halogen, in a suitable solvent, optionally in the presence of a Lewis acid.08-12-2010

Helena Catalan-Asenjo, Muenchen DE

Patent application numberDescriptionPublished
20090218232Method for the Pre-Treatment of Titanium Components for the Subsequent Coating Thereof - A method for the pre-treatment of titanium components for the subsequent coating thereof is provided. The method includes at least the following steps: a) etching of the component in an acidic solution containing fluoride and nitric acid (HNO3); b) activation pickling of the etched component in a solution containing at least sodium nitrate (NaNO3) and tetrafluoroboric acid (HBF4); and c) activation of the activation-pickled component in a bath containing acid or in an acidic bath containing nickel.09-03-2009

Helena Ceric, Zagreb HR

Patent application numberDescriptionPublished
20090137613PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS - The present invention is concerned with new pharmaceutically acceptable salts of valacyclovir, polymorphic forms, processes for preparing the new pharmaceutically acceptable salts and new polymorphic forms, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same.05-28-2009
20110196008POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF - New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.08-11-2011
20120022124POLYMORPHS OF ELTROMBOPAG AND ELTROMBOPAG SALTS AND PROCESSES FOR PREPARATION THEREOF - New polymorphs of Eltrombopag and Eltrombopag ethanolamine salt have been obtained and characterized. These polymorphs and pharmaceutical compositions comprising them are useful, for example, in treating conditions leading to thrombocytopenia.01-26-2012

Patent applications by Helena Ceric, Zagreb HR

Helena Cheminet, Gradignan FR

Patent application numberDescriptionPublished
20090081260NATURALLY RESORBABLE POLYACRYLAMIDE GEL, PRODUCTION PROCESS AND USES - A biodegradable polyacrylamide gel that is obtained from acrylamide monomers that are connected to one another by at least one amino acid includes at least one acryloylated amine or acryloylated amide group, or by at least one amino acid oligopeptide that comprises at least one acryloylated amine or acryloylated amide group. The process for synthesis of this gel and its uses are also disclosed.03-26-2009
20100040571POLYMERIC DEPILATORY COMPOSITION WITH CONTROLLED TEMPERATURE SETTING OF USE - The object of the invention is a polymeric depilatory (epilatory) composition including: a. at least one basic compound permitting adherence to the hair, b. at least one wax-based rheology regulating compound, and c. at least one microwave absorber compound.02-18-2010

Helena Corneliusson, Bohus SE

Patent application numberDescriptionPublished
20090192483INITIAL PRODUCT ADAPTABLE TO SERVE AS A GARMENT AND ITS METHOD OF MANUFACTURING - An initial product (07-30-2009
20090204093GARMENT FOR USE WITH AN ABSORBENT STRUCTURE AND ITS METHOD OF MANUFACTURE - A garment such as a diaper, training pant, pull-up diaper, adult incontinence pant and diaper holder. The garment includes a chassis for receiving the absorbent structure. The chassis includes a first lateral margin and a second lateral margin. The first and second lateral margins are joined to a central structure along a first line of joinder and a second line of joinder, respectively, the first and second lines of joinder extending substantially parallel to the longitudinal axis. The first and second lateral margins have a first end region, a second end region and a central region. The first and second lateral margins has a material which is elastically extensible in at least the longitudinal direction in the central region and elastically extensible in at least one of the first and second end regions in at least the transverse direction. A method of manufacturing a garment is also disclosed.08-13-2009
20100137823ABSORBENT ARTICLE WITH IMPROVED FIT - An absorbent article includes a chassis extending about a longitudinal axis and having a topsheet, a backsheet and an absorbent structure disposed between the topsheet and the backsheet. The chassis has a first transverse axis dividing the absorbent structure into a front body panel terminating in a front waist region and a rear body panel terminating in a rear waist region. The rear waist region has a first elastic region. The chassis is delimited by opposed longitudinal edges and opposed transverse edges. In the rear waist region, the absorbent structure terminates at a first distance from the transverse edge and the first elastic region extends substantially parallel to the transverse edge and spaced therefrom by a second distance and spaced from the absorbent structure by a third distance. The third distance is greater than said second distance or substantially equal thereto.06-03-2010
20100170614METHOD FOR CUTTING OUT DISCRETE FASTENING ELEMENTS AND APPLYING THESE TO AN ABSORBENT ARTICLE, AND THE ABSORBENT ARTICLE - A method for cutting discrete fastening elements (07-08-2010

Patent applications by Helena Corneliusson, Bohus SE

Helena Corominola Ocana, Barcelona ES

Patent application numberDescriptionPublished
20080206356Pharmaceutical Compositions for the Treatment of Neurodegenerative Disorders - Pharmaceutical compositions comprising an effective amount of a tungsten (VI) compound, preferably of a tungstate salt, and more preferably of sodium tungstate (Na08-28-2008

Helena De Voogd-Claessen, Leiden NL

Patent application numberDescriptionPublished
20080224934Tight-Fitting Garment Including a Sensor for Measuring Length and/or Shape - A tight-fitting garment comprising a dipole resonator which is adapted to vary its length and/or shape in conformity with the length and/or shape variations of a person wearing the garment. The length and/or shape of the resonator determines the resonance frequency which can be detected by a reflection analyser. The dipole resonator comprises at least one elastic core around which a conductive wire is wound. The dipole resonator is further suitable to elastically deform along with the tight-fitting garment.09-18-2008

Helena Farnikova, Regensburg DE

Patent application numberDescriptionPublished
20120035523SYSTEM FOR TREATMENT OF BLOOD - The present invention relates to a system for the treatment of blood, in particular a highly efficient system for the safe removal of CO2 and bicarbonates from the blood in a blood circuit connected to a patient by means of a venous-venous connection having at least an inlet or tube line (02-09-2012

Helena Gleskova, Princeton, NJ US

Patent application numberDescriptionPublished
20080303436Method for pattern metalization of substrates - A method for forming an adhesion layer in contact with a first surface of a substrate and a surface of a layer having electrically conductive properties using electrophotographic imaging compound as a mask is provided. The adhesion layer improves the lamination properties of the electrically conductive layer to the substrate. The improved lamination properties to facilitate and increase the reliability and quality of a resulting product having an electronic circuit formed in accordance with the present invention. The method disclosed herein is well suited for use with rigid polymeric substrates and flexible polymeric substrates.12-11-2008

Helena Grinberg-Rashi, Raanana IL

Patent application numberDescriptionPublished
20100145131METHODS AND KITS FOR PREDICTING CANCER METASTASIS - A method of predicting CNS metastasis of a non-neuronal cancer in a subject is disclosed. The method comprises determining a level and/or activity of N-cadherin (CDH2), in a sample of the subject wherein an increase in the CDH2 with respect to an unaffected sample is indicative of the CNS metastasis of the non-neural cancer. The method further comprises determining a level and/or activity or kinesin family member C1 (KIFC1) and/or Fetal Alzheimer Antigen (FALZ1) in the sample wherein an increase in KIFC1 and a decrease in FALZ with respect to an unaffected sample is further indicative of the CNS metastasis of the non-neural cancer. The method may be used for selection of a treatment regimen. In addition, kits for prediction CNS metastasis are disclosed.06-10-2010

Helena GybÄck, Sodertalje SE

Patent application numberDescriptionPublished
201003313412-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN DERIVATIVES 774 - The present invention relates to compounds of formula (I),12-30-2010

Helena GybÄck, Sodertalje SE

Patent application numberDescriptionPublished
20080255106Novel 2-Phenyl-Imidazo[4,5-B]Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase for the Treatment of Dementia and Neurodegenerative Disorders - Compounds of formula I10-16-2008
20090192190Benzoic Acid Derivatives that are Modulators or Agonists of GlyR - Compounds of formula I,07-30-2009
201003313412-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN DERIVATIVES 774 - The present invention relates to compounds of formula (I),12-30-2010

Patent applications by Helena GybÄck, Sodertalje SE

Helena Gylling, Helsinki FI

Patent application numberDescriptionPublished
20100179113STANOL COMPOSITION AND THE USE THEREOF - A stanol composition containing in addition to sitostanol as the main component, also a substantial amount of at least 10% campestanol has been found to effectively lower serum cholesterol levels when incorporated in edible commodities. Upon esterification the composition is especially useful in edible fats and oils and in fat-containing foods.07-15-2010

Patent applications by Helena Gylling, Helsinki FI

Helena Hagelin-Weaver, Gainsville, FL US

Patent application numberDescriptionPublished
20100147699CONCURRENT O2 GENERATION AND CO2 CONTROL FOR ADVANCED LIFE SUPPORT - A device for the concurrent oxygen generation and control of carbon dioxide for life support system involves two stages, where a first stage removes CO06-17-2010

Helena Johansson, Torslanda SE

Patent application numberDescriptionPublished
20080210246Draping Product with an Adhesive Edge, Incision Film or Tape - The present invention relates to a draping product with an adhesive edge, incision film or tape, provided with a soft, skin friendly adhesive. In accordance with invention, the draping product, the incision film or the tape is leakproof in accordance with the MHC Leakage Test with a groove depth of 50 micrometres.09-04-2008

Helena Johnansson, Wurzburg DE

Patent application numberDescriptionPublished
20100141270PROCESS AND DEVICE TO MEASURE AT LEAST ONE QUALITATIVE VALUE OF A FIBROUS WEB - A process to measure at least one qualitative measure of a moving fibrous web. The fibrous web being a web of paper or cardboard. The process including the steps of influencing, evaluating and determining. The influencing step includes the influencing of at least one microwave resonator by the fibrous web. The evaluating step including the evaluating of at least one resonance curve of the at least one microwave resonator. The determining step including the determining of at least one quality measure of the fibrous web dependent upon results of the evaluating step.06-10-2010

Helena Katchman, Givataim IL

Patent application numberDescriptionPublished
20090324607Therapeutic Transplantation Using Developing, Human or Porcine, Renal or Hepatic, Grafts - A method of treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof is disclosed. The method is effected by transplanting into the subject tissue derived from a human or porcine, kidney or liver, the kidney or liver being at a selected gestational stage.12-31-2009
20100021433Disease treatment via developing non-syngeneic graft transplantation - A method of providing a pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue function to a mammalian subject is provided. The method comprises transplanting into the subject a developing mammalian pancreatic, lymphoid/hematopietic or pulmonary organ/tissue graft, respectively, thereby generating a functional pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue, respectively, for providing the pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue function, respectively, to the subject.01-28-2010
20100221270THERAPEUTIC TRANSPLANTATION USING DEVELOPING, HUMAN OR PORCINE, RENAL OR HEPATIC, GRAFTS - A method of treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof is disclosed. The method is effected by transplanting into the subject tissue derived from a human or porcine, kidney or liver, the kidney or liver being at a selected gestational stage.09-02-2010

Patent applications by Helena Katchman, Givataim IL

Helena Kaukinen, Paimio FI

Patent application numberDescriptionPublished
20110071203TRANSMUCOSAL VETERINARY COMPOSITION COMPRISING DETOMIDINE - The present invention relates to a veterinary composition in a semisolid form adapted for transmucosal administration for providing sedation and analgesia in large animals such as horses and cattle. The semisolid transmucosal composition of the invention comprises detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. The composition provides a rapid onset of action while having low irritation potential in the oral mucosa.03-24-2011

Helena Lam, Thousand Oaks, CA US

Patent application numberDescriptionPublished
20090283441Cosmetics kit - A cosmetics kit including a fountain is described. The cosmetics kit comprises a base with a fountain attached for circulating a fluid and at least one cosmetic connectable with the base. Additionally, a mixing bowl connectable with the base is included to allow the user to mix custom cosmetics such as lip gloss and perfume with mixing accessories included with the cosmetics kit. Furthermore, a scented oil is added to the circulating fluid in the fountain to create an aromatherapy experience.11-19-2009

Helena Larsson, Kungalv SE

Patent application numberDescriptionPublished
20090039060Lasercutting With Scanner - The embodiments described relate to a laser cutting method suitable for cutting multilayered or painted materials such as for example car bodies. The method involves the step of scanning a low laser beam a plurality of turns along an intended cut edge. Utilizing the described cutting method, the paint located in the vicinity of the cut edge is only slightly affected by the heat generated by the laser beam.02-12-2009

Helena Litani, Thornhill CA

Patent application numberDescriptionPublished
20100064229AUTOMATIC PERSONALIZATION OF USER VISUALIZATION AND INTERACTION IN A SERVICE-ORIENTED ARCHITECTURE INTERFACE - A system for automatically generating visualization artifacts corresponding to related service operation interfaces. A user level visualization finite state machine instance is created for a specific service instance based on user activation and deactivation of service operations in the specific service instance and user selection of a start visualization state. The service operations are included in a service level visualization finite state machine instance for the specific service instance. Visualization artifacts are automatically generated based on the user level visualization finite state machine instance and parameterized entities bound to a concrete visualization component. The visualization artifacts are outputted in a service operation interface of the specific service instance for a user to visualize and interact with, resulting in the elimination of individual user unwanted server side function in the units of service operations without server side processing.03-11-2010
20100082379INFERENTIAL BUSINESS PROCESS MONITORING - Methods, systems and computer program products for inferential business process monitoring. Exemplary embodiments include an inferential business process monitoring method, including deriving an optimal set of key performance indicators from a service level agreement specification, determining metrics to compute the key performance indicators from the service level agreement specification, assigning and configuring monitoring agents to retrieve the metrics to obtain the key performance indicators, deploying the monitoring agents and delivering key performance indicator metrics observed by the monitoring agents.04-01-2010
20100094883Method and Apparatus for Integrated Entity and Integrated Operations of Personalized Data Resource Across the World Wide Web for Online and Offline Interactions - Embodiments of the invention provide a method and apparatus for integrated entity of personalized data resource across the WWW with integrated operations. Such embodiments can reside on premises (or service side) as an integrated personalized data resource which is constructed from each of a number of web applications over the Internet that fetch and provide a piece of user information. One embodiment of the invention is directed to a computer that has the method and apparatus associated with the designated user. It is operable to receive informational data from multiple information sources, wherein the data received from each source has a user or web application defined association with a plurality of semantic categories via tagging, and the data received from at least two different sources pertains to the same category (or tag).04-15-2010

Helena Mira Aparicio, Valencia ES

Patent application numberDescriptionPublished
20100047212USE OF THE PEDF FACTOR TO INDUCE CELL REGENERATION - Use of the PEDF factor to induce cell regeneration. The present invention refers to the use of the molecule PEDF for the manufacture of medicines to activate processes included in the group of regenerative processes, such as skin regeneration, wound healing, cell therapy for cardiac, neural, or hematopoietic regeneration. It also refers to the manufacture/use of pharmaceutical compounds that contain an efficient quantity of the PEDF factor for stem cell self-renewal.02-25-2010

Helena Modrzejewska, Warszawa PL

Patent application numberDescriptionPublished
20120065226SALTS OF TIOTROPIUM WITH 10-CAMPHORSULFONIC ACID - The present invention relates to novel tiotropium salts with 10-camphorsulphonic acid of formula (I), its optical isomers or their mixtures, their monohydrates, their anhydrous crystalline forms and processes for the preparation thereof, as well as to pharmaceutical compositions containing the same and to the use of novel salts for the treatment of respiratory tract diseases.03-15-2012

Helena Mora-Jensen, Copenhagen DK

Patent application numberDescriptionPublished
20100286091IMIDAZOLIDINONE COMPOUNDS, METHODS TO INHIBIT DEUBIQUITINATION AND METHODS OF TREATMENT - The present invention features imidazolidinone compounds and pharmaceutical compositions of imidazolidinone compounds. The compounds of the invention are utilized in methods of treating a deubiquitination-related disorder in a subject and inhibiting p97-associated deubiquitination.11-11-2010

Helena Myrberg, Stockholm SE

Patent application numberDescriptionPublished
20100279918Chimeric Constructs Between Cancer-Homing Peptides and Cell-Penetrating Peptides Coupled to Anticancer Drugs and/or Diagnostic Agent/Agents - A construct comprising a cancer-homing peptide, an optional linker and a cell-penetrating peptide coupled to an anticancer drug and/or a diagnostic agent is disclosed. The homing peptide is for example a linear pentapeptide such as CREKA (SEQ ID NO:1), AREKA (SEQ 5 ID NO: 23) or CREKA0 (SEQ ID NO: 23), or a cyclic nonapeptide CPGPEGAGC (SEQ ID NO:2), and the cell-penetrating peptide is for example one of the peptides SEQ ID NO:3-SEQ ID NO:20. The anticancer drug may be selected from alkylating agents, antimetabolites and cytotoxic antibiotics, and the diagnostic agent may be a fluorescent label. Further, a method of delivering an anticancer drug and/or a diagnostic agent into a cancer cell 0 comprising administration of a construct according to the invention in vivo or in vitro is described.11-04-2010

Helena Orszanska, Edmonton CA

Patent application numberDescriptionPublished
20110293671BACTERIOPHAGE COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS - A respirable composition for treatment of a bacterial infection includes one or more active bacteriophages in combination with a pharmaceutically acceptable respirable carrier. The composition includes a carbohydrate carrier, and is prepared as fine powder. In another aspect, bacteriophages are provided in a liquid carrier for administration by nebulization. In one aspect, the bacteriophages have anti-bacterial activity against one or more species or strains of 12-01-2011

Helena Ostolaza Etxabe, Leioa ES

Patent application numberDescriptionPublished
20100285068METHOD FOR THE INTERNALIZATION OF NON-INVASIVE BACTERIA IN EUKARYOTE CELLS - The present invention relates to the use of adenylate cyclase toxin (ACT), or a functionally equivalent variant thereof, as an inducing agent for the internalization of non-invasive bacteria in eukaryotic cells. Due to ACT, said non-invasive bacterium can move through the plasma membrane of a eukaryotic cell and transfer plasmid DNA to said cell, which is useful for releasing or introducing molecules of therapeutic interest, for example, antigens, in the interior of the eukaryotic cell, thereby triggering the immune response.11-11-2010

Helena Päbel, Sandviken SE

Patent application numberDescriptionPublished
20100322727DRILLING TOOL OF THE LOOSE TOP TYPE - A drilling tool of the loose top type includes a basic body having two bendable branches having inner support surfaces that are resiliently pressable against side contact surfaces of a replaceable loose top. The mounting of the loose top is affected by turning-in from an initial position to an operative end position. An abutting edge along each side contact surface then bends out the branches and subjects the branches to a spring force that reaches a maximum in a dead position so as to then decrease somewhat up to the operative end position. During the final phase of the rotary motion, the operator obtains, in a tactile and/or auditory way, confirmation of the loose top indeed reaching its operative end position.12-23-2010
20100322729DRILLING TOOL FOR CHIP REMOVING MACHINING AS WELL AS A LOOSE TOP AND A BASIC BODY THEREFOR - A loose top for drilling tools, including front and rear ends, a pair of envelope part surfaces concentric with a center axis, and two chip flutes countersunk in relation to the pair of envelope part surfaces between which two bars project radially from a central core, the front end including a cutting edge and at least one clearance surface positioned rotationally behind the cutting edge, the rear end forming an axial contact surface. The loose top includes two opposite side contact surfaces against which elastically bendable branches of a tool basic body are pressed in use, a pair of convex guide surfaces situated axially behind the side contact surfaces, the guide surfaces being concentric with the center axis and radially spaced-apart from the center axis at a distance that is less than the radial distance between the center axis and a respective side contact surface, and a pair of torque-carrying tangential contact surfaces that are situated radially inside the envelope part surfaces and outside the side contact surfaces. The axial contact surface extends perpendicular to the center axis between borderlines adjacent to the two envelope part surfaces.12-23-2010

Helena Päbel, Sandviken SE

Patent application numberDescriptionPublished
20100322727DRILLING TOOL OF THE LOOSE TOP TYPE - A drilling tool of the loose top type includes a basic body having two bendable branches having inner support surfaces that are resiliently pressable against side contact surfaces of a replaceable loose top. The mounting of the loose top is affected by turning-in from an initial position to an operative end position. An abutting edge along each side contact surface then bends out the branches and subjects the branches to a spring force that reaches a maximum in a dead position so as to then decrease somewhat up to the operative end position. During the final phase of the rotary motion, the operator obtains, in a tactile and/or auditory way, confirmation of the loose top indeed reaching its operative end position.12-23-2010
20100322729DRILLING TOOL FOR CHIP REMOVING MACHINING AS WELL AS A LOOSE TOP AND A BASIC BODY THEREFOR - A loose top for drilling tools, including front and rear ends, a pair of envelope part surfaces concentric with a center axis, and two chip flutes countersunk in relation to the pair of envelope part surfaces between which two bars project radially from a central core, the front end including a cutting edge and at least one clearance surface positioned rotationally behind the cutting edge, the rear end forming an axial contact surface. The loose top includes two opposite side contact surfaces against which elastically bendable branches of a tool basic body are pressed in use, a pair of convex guide surfaces situated axially behind the side contact surfaces, the guide surfaces being concentric with the center axis and radially spaced-apart from the center axis at a distance that is less than the radial distance between the center axis and a respective side contact surface, and a pair of torque-carrying tangential contact surfaces that are situated radially inside the envelope part surfaces and outside the side contact surfaces. The axial contact surface extends perpendicular to the center axis between borderlines adjacent to the two envelope part surfaces.12-23-2010
20110236145ROTATABLE TOOL FOR CHIP REMOVING MACHINING AS WELL AS A LOOSE TOP AND A BASIC BODY THEREFOR - A rotatable tool for chip removing machining, including a basic body having front and rear ends between which there extends a first geometrical center axis (C09-29-2011

Helena Pardo Minetti, Montevideo UY

Patent application numberDescriptionPublished
20120128929Process of Preparing Magnetic Graphitic Materials, and Materials Thereof - A process of preparing magnetic graphitic materials from graphite in a second container (05-24-2012

Helena Pardos Minetti, Montevideo UY

Patent application numberDescriptionPublished
20080237533Process for Preparing Magnetic Graphitic Materials, and Materials Thereof - A process of preparing magnetic graphitic materials from graphite in a second container (10-02-2008

Helena Peurasaari, Molnlycke SE

Patent application numberDescriptionPublished
20090069770MULTI FUNCTION WRAPPER - The invention refers to a packing wrapper (03-12-2009

Helena Skoglar, Uppsala SE

Patent application numberDescriptionPublished
20120091063METHOD IN A CHROMATOGRAPHY SYSTEM - A method for determining binding capacities of a chromatography column (04-19-2012

Helena Stadniychuk, Eagan, MN US

Patent application numberDescriptionPublished
20100327248CELL PATTERNING WITH MULTIPLE HARD MASKS - A method of making a memory cell or magnetic element by using two hard masks. The method includes first patterning a second hard mask to form a reduced second hard mask, with a first hard mask being an etch stop for the patterning process, and then patterning the first hard mask to form a reduced first hard mask by using the reduced second hard mask as a mask and using an etch stop layer as an etch stop. After patterning both hard masks, then patterning a functional layer by using the reduced first hard mask as a mask. In the resulting memory cell, the first hard mask layer is also a top lead, and the diameter of the first hard mask layer is at least essentially the same as the diameter of the etch stop layer, the adhesion layer, and the functional layer.12-30-2010

Helena Ticha, Srch CZ

Patent application numberDescriptionPublished
20090173960SEMICONDUCTOR LIGHT EMITTING DEVICE WITH PRE-FABRICATED WAVELENGTH CONVERTING ELEMENT - A semiconductor light emitting device is provided with a separately fabricated wavelength converting element. The wavelength converting element, of e.g., phosphor and glass, is produced in a sheet that is separated into individual wavelength converting elements, which are bonded to light emitting devices. The wavelength converting elements may be grouped and stored according to their wavelength converting properties. The wavelength converting elements may be selectively matched with a semiconductor light emitting device, to produce a desired mixture of primary and secondary light.07-09-2009
20100109568COMMON OPTICAL ELEMENT FOR AN ARRAY OF PHOSPHOR CONVERTED LLIGHT EMITTING DEVICES - A device is provided with an array of a plurality of phosphor converted light emitting devices (LEDs) that produce broad spectrum light. The phosphor converted LEDs may produce light with different correlated color temperature (CCT) and are covered with an optical element that assists in mixing the light from the LEDs to produce a desired correlated color temperature. The optical element may be bonded to the phosphor converted light emitting devices. The optical element may be a dome mounted over the phosphor converted light emitting devices and filled with an encapsulant.05-06-2010
20120043564COMMON OPTICAL ELEMENT FOR AN ARRAY OF PHOSPHOR CONVERTED LIGHT EMITTING DEVICES - A device is provided with at least one light emitting device (LED) die mounted on a submount with an optical element subsequently thermally bonded to the LED die. The LED die is electrically coupled to the submount through contact bumps that have a higher temperature melting point than is used to thermally bond the optical element to the LED die. In one implementation, a single optical element is bonded to a plurality of LED dice that are mounted to the submount and the submount and the optical element have approximately the same coefficients of thermal expansion. Alternatively, a number of optical elements may be used. The optical element or LED die may be covered with a coating of wavelength converting material. In one implementation, the device is tested to determine the wavelengths produced and additional layers of the wavelength converting material are added until the desired wavelengths are produced.02-23-2012

Patent applications by Helena Ticha, Srch CZ

Helena Ticha, Czech Republic CZ

Patent application numberDescriptionPublished
20110062469MOLDED LENS INCORPORATING A WINDOW ELEMENT - A light emitter includes a light-emitting device (LED) die and an optical element over the LED die. The optical element includes a lens, a window element, and a bond at an interface disposed between the lens and the window element. The window element may be a wavelength converting element or an optically flat plate. The window element may be directly bonded or fused to the lens, or the window element may be bonded by one or more intermediate bonding layers to the lens. The bond between the window element and the lens may have a refractive index similar to that of the window element, the lens, or both.03-17-2011

Helena Tlaskalova-Hogenova, Prague CZ

Patent application numberDescriptionPublished
20090118173TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASES - The present invention relates to the use of heat shock proteins, or fragments thereof, for the treatment and/or prevention of Inflammatory Bowel Diseases. Preferably bacterial and/or mammalian heat shock proteins belonging to the HSP70 families are used.05-07-2009

Helena Twardowska, Loveland, OH US

Patent application numberDescriptionPublished
20120135147HIGH BUILD LOW TEMPERATURE EXOTHERM EXTRUDABLE MATERIAL - A high build tooling compound suited for plug building by extrusion process with conventional FRP dispensing equipment is described. The material is based on urethane hybrid and unsaturated polyester resin mixture with additives to provide low shrinkage and low exotherm. The formulation allows building a desired part thicknesses from 0.5 to 3 inches in one application. Methods of making a plug are also described.05-31-2012

Helena Twardowska, Cincinnati, OH US

Patent application numberDescriptionPublished
20120034373MATERIAL AND APPLICATOR FOR PINHOLE AND SMALL DEFECT REPAIR - A method for finishing a repaired surface is described. The method includes wiping a sealer on the repaired surface to seal microporosity in the repaired surface, the sealer consisting essentially of a mixture of polymer, at least one filler, solvent, and optionally microspheres; and applying a top coat to the sealed surface without sanding the sealed surface, the top coat being free of visible pinholes. Sealers and tools for applying surface sealers are also described.02-09-2012
20120040173LOW DENSITY CORING MATERIAL - A low density coring material is described. In one embodiment, the low density coring material consists essentially of: about 40 to about 80 wt % resin; 0 to about 50 wt % monomer; 0 to about 5 wt % dispersion aid; 0 to about 5 wt % accelerator; about 3 to about 7 wt % microspheres; and about 1 to about 5 wt % catalyst; wherein a density of the cured coring material is less than about 5.0 lbs/gal. Composites made using the low density coring material and methods of making composites are also described.02-16-2012
20120040174LOW DENSITY CORING MATERIAL - A low density coring material is described. In one embodiment, the low density coring material consists essentially of: about 40 to about 80 wt % resin, the resin consisting essentially of vinyl ester resin or a combination of vinyl ester resin and polyester resin; 0 to about 50 wt % monomer; 0 to about 5 wt % dispersion aid; 0 to about 5 wt % accelerator, or inhibitor, or both; about 3 to about 10 wt % microspheres; 0 to about 20 wt % fiber; 0 to about 20 wt % filler; and about 1 to about 5 wt % catalyst; wherein a density of the cured coring material is less than about 5.0 lbs/gal. Composites made using the low density coring material and methods of making composites are also described.02-16-2012

Helena Van Den Bussche, Malmo SE

Patent application numberDescriptionPublished
20110207765TOPICAL COMPOSITION COMPRISING A COMBINATION OF AT LEAST TWO PENETRATION ENHANCING AGENTS - The present invention relates to a composition for improved transdermal drug delivery comprising a drug, a combination of at least two penetration enhancing agents, wherein at least one of the penetration enhancing agents is selected from the group consisting of esters of saturated or unsaturated fatty acids and lower alcohols, and iso-form alcohols; wherein at least one of the penetration enhancing agents is selected from the group consisting of aliphatic diols and triols; and wherein the components are present in a non-aqueous solvent system. A preferred topical composition comprises the active substance imiquimod and the penetration enhancing agents isopropyl myristate and propylene glycol.08-25-2011

Helena Yusuf-Makagiansar, San Diego, CA US

Patent application numberDescriptionPublished
20100068693Nutrient Monitoring and Feedback Control for Increased Bioproduct Production - The present invention pertains to methods of increasing the efficiency of producing a bioproduct. In some embodiments, the method increases the quantity of a bioproduct produced, or decreases bioproduct production time, in a bioreactor cell culture producing the bioproduct, the method comprising, (a) intermittently or continuously analyzing the concentration of one or more nutrients in the bioreactor cell culture; and (b) adding to the bioreactor cell culture additional nutrient media when the concentration of the one or more nutrients is lower than a target value.03-18-2010

Helena Zelmanovich, Deer Park, NY US

Patent application numberDescriptionPublished
20080198816MULTIPLE APPEARANCE PROTOCOL FOR TIMELY ORGANIZED AD HOC NETWORK - The present invention comprises a plurality of timely organized ad hoc data communications networks and a method for data communication. A network from the plurality of networks includes media-independent communications links and plurality of network nodes, where a network node in the plurality could be coupled to at least one other network node via a media independent communication link, and a plurality of access points, where each access point in the plurality is coupled to at least one other access point via another media-independent communications link. The network communicates during a data collection cycle that includes a broadcast interval, a time-slotted communications interval and a random access time-slotted communications interval. The plurality of network nodes are arranged in a self-assigned hierarchy where one or more nodes in the plurality of network nodes can be assigned more than one time slot to transmit the network information messages.08-21-2008

Helena Zelmanovick, Deer Park, NY US

Patent application numberDescriptionPublished
20100115414TOPOGRAPHICAL DISPLAY GENERATOR FOR AD HOC NETWORK - The present invention comprises a computer apparatus for displaying the topology of a timely organized ad hoc network, the apparatus including a processor, a memory, a computer-readable medium, an input device coupled to the processor, a radio frequency transceiver coupled to the processor; a communications interface coupled to the memory, a display coupled to the processor, and software copied from the computer-readable medium into the memory by the processor that, when executed, causes the processor to obtain a diagram of the network location from the input device or computer readable medium, obtain the identities of the devices comprising the network from the input device or computer readable medium, determine the communication links between the network devices, and graphically represent on the display the devices and the connection links on the diagram.05-06-2010